+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2020-2024 - Product Image

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2020-2024

  • ID: 5135355
  • Report
  • July 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Baxter International Inc.
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Mylan NV
  • MORE
Global Chemotherapy-induced Nausea And Vomiting Drugs Market 2020-2024

The chemotherapy-induced nausea and vomiting drugs market is poised to grow by $ 525 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. The report on chemotherapy-induced nausea and vomiting drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing cancer population driving the market growth and approval of new drugs fuels the market growth.
Chemotherapy-induced nausea and vomiting drugs market analysis includes therapy segment and geographic landscapes

The chemotherapy-induced nausea and vomiting drugs market is segmented as below:

By Therapy
  • Serotonin receptor antagonists
  • NK1 receptor antagonists
  • Others
By Geographic Landscapes
  • North America
  • Europe
  • APAC
  • ROW
This study identifies the growing preference for chemotherapy drugs in developing countries as one of the prime reasons driving chemotherapy-induced nausea and vomiting drugs market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The chemotherapy-induced nausea and vomiting drugs market covers the following areas:
  • Chemotherapy-induced nausea and vomiting drugs market sizing
  • Chemotherapy-induced nausea and vomiting drugs market forecast
  • Chemotherapy-induced nausea and vomiting drugs market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chemotherapy-induced nausea and vomiting drugs market vendors that include Baxter International Inc., Cipla Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Mylan NV, Novartis AG, Sanofi, and Sun Pharmaceutical Industries Ltd. Also, chemotherapy-induced nausea and vomiting drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Baxter International Inc.
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Mylan NV
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Therapy
  • Market segments
  • Comparison by Therapy
  • Serotonin receptor antagonists - Market size and forecast 2019-2024
  • NK1 receptor antagonists - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Therapy
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Baxter International Inc.
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Other1 - Market share 2019-2024 (%)
22: Comparison by Other1
23: Serotonin receptor antagonists - Market size and forecast 2019-2024 ($ million)
24: Serotonin receptor antagonists - Year-over-year growth 2019-2024 (%)
25: NK1 receptor antoagonists - Market size and forecast 2019-2024 ($ million)
26: NK1 receptor antoagonists - Year-over-year growth 2019-2024 (%)
27: Others - Market size and forecast 2019-2024 ($ million)
28: Others - Year-over-year growth 2019-2024 (%)
29: Market opportunity by Other1
30: Customer Landscape
31: Market share by geography 2019-2024 (%)
32: Geographic comparison
33: North America - Market size and forecast 2019-2024 ($ million)
34: North America - Year-over-year growth 2019-2024 (%)
35: Europe - Market size and forecast 2019-2024 ($ million)
36: Europe - Year-over-year growth 2019-2024 (%)
37: APAC - Market size and forecast 2019-2024 ($ million)
38: APAC - Year-over-year growth 2019-2024 (%)
39: ROW - Market size and forecast 2019-2024 ($ million)
40: ROW - Year-over-year growth 2019-2024 (%)
41: Key leading countries
42: Market opportunity by geography ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Baxter International Inc. - Overview
50: Baxter International Inc. - Business segments
51: Baxter International Inc. - Key offerings
52: Baxter International Inc. - Key customers
53: Baxter International Inc. - Segment focus
54: Cipla Inc. - Overview
55: Cipla Inc. - Business segments
56: Cipla Inc. - Key offerings
57: Cipla Inc. - Key customers
58: Cipla Inc. - Segment focus
59: F. Hoffmann-La Roche Ltd. - Overview
60: F. Hoffmann-La Roche Ltd. - Business segments
61: F. Hoffmann-La Roche Ltd. - Key offerings
62: F. Hoffmann-La Roche Ltd. - Key customers
63: F. Hoffmann-La Roche Ltd. - Segment focus
64: GlaxoSmithKline Plc - Overview
65: GlaxoSmithKline Plc - Business segments
66: GlaxoSmithKline Plc - Key offerings
67: GlaxoSmithKline Plc - Key customers
68: GlaxoSmithKline Plc - Segment focus
69: Merck & Co. Inc. - Overview
70: Merck & Co. Inc. - Business segments
71: Merck & Co. Inc. - Key offerings
72: Merck & Co. Inc. - Key customers
73: Merck & Co. Inc. - Segment focus
74: Mylan NV - Overview
75: Mylan NV - Business segments
76: Mylan NV - Key offerings
77: Mylan NV - Key customers
78: Mylan NV - Segment focus
79: Novartis AG - Overview
80: Novartis AG - Business segments
81: Novartis AG - Key offerings
82: Novartis AG - Key customers
83: Novartis AG - Segment focus
84: Sanofi - Overview
85: Sanofi - Business segments
86: Sanofi - Key offerings
87: Sanofi - Key customers
88: Sanofi - Segment focus
89: Sun Pharmaceutical Industries Ltd. - Overview
90: Sun Pharmaceutical Industries Ltd. - Business segments
91: Sun Pharmaceutical Industries Ltd. - Key offerings
92: Sun Pharmaceutical Industries Ltd. - Key customers
93: Sun Pharmaceutical Industries Ltd. - Segment focus
94: Currency conversion rates for US$
95: Research Methodology
96: Validation techniques employed for market sizing
97: Information sources
98: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Baxter International Inc.
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Mylan NV
  • MORE
The publisher recognizes the following companies as the key players in the global chemotherapy-induced nausea and vomiting drugs market: Baxter International Inc., Cipla Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Mylan NV, Novartis AG, Sanofi, and Sun Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing preference for chemotherapy drugs in developing countries."

According to the report, one of the major drivers for this market is the growing cancer population driving the market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • Baxter International Inc.
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll